JOHN CRAVER: Open Payments
NPI 1427899897 · FOLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $991 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $105 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Alkermes, Inc. | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 3 | $60 |
| ABBVIE INC. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: AUSTEDO XR, REXULTI, ARISTADA, SPRAVATO, VRAYLAR, FANAPT, CAPLYTA.
Industry payments across AL — which companies pay providers there.
